Doctor profile · Federal record
Dr. DAVID OHOTNICKY, APRN
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · Primary Care Nurse Practitioner · TORRINGTON, CT
- NPI 1699067314
- Accepts Medicare
- MIPS 78.7 / 100 · 2023
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
780 LITCHFIELD ST
TORRINGTON, CT 067906268
(860) 496-2198
Credentials & registration
- NPI registered
- May 2011 — 15 yrs on file
- Profile last updated
- January 8, 2015
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Connecticut #004658
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699067314. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
581
Distinct HCPCS
4
Medicare allowed
$45,111
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 432 | 229 | $87 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 99 | 52 | $31 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 27 | 27 | $119 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 23 | 20 | $59 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 147. This provider delivers 4.0× the peer median.Open Payments
Industry payments received
All-time total
$4,898
Transactions
211
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 41 | $793.55 | |
| Lilly USA, LLC | 27 | $660.01 | |
| Amgen Inc. | 25 | $468.84 | |
| Novo Nordisk Inc | 20 | $460.19 | |
| Xeris Pharmaceuticals, Inc. | 19 | $401.56 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $342.76 | |
| Dexcom, Inc. | 14 | $267.22 | |
| Antares Pharma, Inc. | 10 | $192.79 | |
| Novartis Pharmaceuticals Corporation | 9 | $174.04 | |
| AstraZeneca Pharmaceuticals LP | 9 | $168.75 | |
| Alexion Pharmaceuticals, Inc. | 6 | $132.96 | |
| ABBVIE INC. | 5 | $109.05 | |
| Ascensia Diabetes Care Us Inc. | 4 | $89.83 | |
| Ascendis Pharma Inc | 4 | $89.31 | |
| SANOFI-AVENTIS U.S. LLC | 4 | $88.77 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,705
Patients
1,114
Total drug cost
$3,856,033
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 511 | 125 | $953,589 |
| Trulicity (Dulaglutide) | Brand | 383 | 89 | $732,300 |
| Metformin Hcl | Generic | 345 | 118 | $4,061 |
| Levothyroxine Sodium | Generic | 315 | 102 | $5,142 |
| Jardiance (Empagliflozin) | Brand | 253 | 78 | $416,603 |
| Tresiba Flextouch U-200 (Insulin Degludec) | Brand | 251 | 77 | $323,822 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 243 | 98 | $32,005 |
| Novolog Flexpen (Insulin Aspart) | Brand | 216 | 58 | $255,708 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 206 | 51 | $275,034 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 200 | 58 | $213,372 |